The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2019 | Is there potential to reduce the cost of myeloma therapy?
Here, Vincent Rajkumar, MD, of the Mayo Clinic, Rochester, MN, discusses the high costs of multiple myeloma therapy, even in developed countries. Dr Rajkumar highlights the need for further studies into the optimal length of maintenance therapy, which could help to reduce costs as well as minimizing toxicity and the risk of secondary malignancies. This interview was recorded at the Controversies in Multiple Myeloma (COMy) 2019 meeting held in Paris, France.
